Risk Score for First Chronic Phase of CML (CML-CP Score)

Purpose: To evaluate a patient with CML in the first chronic phase undergoing hematopoietic stem cell transplant using the CML-CP score of Passweg et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with CML in the first chronic phase?

Yes

Age of the patient

years

Gender of the patient

Male

Female

Gender of the donor

Male

Female

Date of CML diagnosis (enter MM-DD-YYYY)

Date of hematopoietic stem cell transplant (enter MM-DD-YYYY)

Donor type

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Total score

Probability of 5 year survival

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Chronic Phase CML Model for Predicting Complete Cytogenetic Response to Imatinib Mesylate
Severity, Prognosis, Stage

Monitoring

Response To Therapy
- European Treatment and Outcome Study for CML (EUTOS) Score

Specialty

Hematology Oncology

Objective

risk factors
severity
prognosis
stage
options
selection
response to therapy

ICD-10

C92.1 - Chronic myeloid leukaemia [CML], BCR/ABL-positive
C92.2 - Atypical chronic myeloid leukaemia, BCR/ABL-negative
Z94.8 - Other transplanted organ and tissue status

Info

Purpose: To evaluate a patient with CML in the first chronic phase undergoing hematopoietic stem cell transplant using the CML-CP score of Passweg et al.

Specialty: Hematology Oncology

Objective: risk factors, severity, prognosis, stage, options, selection, response to therapy

ICD-10: C92.1, C92.2, Z94.8,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path